We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Gene Ontology Database

By Biotechdaily staff writers
Posted on 13 Jul 2005
A database that classifies thousands of human genes by their biologic processes, molecular function, or cellular components is being aided by new bioinformatics technology that guesses the appropriate category for genes not yet classified.

The Gene Ontology database (www.geneontologyt.org) is being developed by the Gene Ontology Consortium, supported by a grant from the U.S. More...
National Genome Research Institute (NHGRI, Washington, DC, USA).

Biomind LLC (Rockville, MD, USA; www.go.biomind.com) is now applying advanced machine learning algorithms to guess the appropriate category for classifying hundreds of previously unclassified genes. The Biomind software makes its guesses by combining information about gene sequences with data mined from a large body of microarray data, incorporating data from a variety of different experiments. The results of this analysis are available on the company's website.

The basic concept is that if a gene behaves and looks similar to the genes in some Gene Ontology category, such as "DNA repair” or "glycolysis,” then perhaps the gene belongs in that category. However, it is not always that simple. "Getting from this basic concept to a working classification system with high accuracy involves a lot of computer science,” explained Dr. Ben Goertzel, CEO of Biomind. Statistical testing suggests that the system's prediction will be roughly 80% accurate, and this accuracy may be improved in the near future by utilizing a broader collection of microarray data.

According to Dr. Goertzel, this information on gene function "should be interesting to anyone doing genomics research. It suggests possible functions for a whole lot of genes that were previously not understood at all, some that were never mentioned in the research literature, because the biologists haven't gotten around to studying them yet. For instance, there are dozens of genes that our software says are associated with programmed cell death--a key cause of aging--and that weren't previously known to have anything to do with anything.”





Related Links:
Gene Ontology
Biomind

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.